ARQT icon

Arcutis Biotherapeutics

78 hedge funds and large institutions have $1.15B invested in Arcutis Biotherapeutics in 2020 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 33 increasing their positions, 12 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
78
Holders Change
+15
Holders Change %
+23.81%
% of All Funds
1.38%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.07%
New
24
Increased
33
Reduced
12
Closed
8
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
PHK
76
Point72 Hong Kong
Hong Kong
$5K +$5K +176 New
Daiwa Securities Group
77
Daiwa Securities Group
Japan
$2K +$2K +82 New
AIG
78
American International Group
New York
$339 +$35 +1,228 +11%
Stifel Financial
79
Stifel Financial
Missouri
-$696K -23,748 Closed
MS
80
Maven Securities
Jersey
-$433K -15,000 Closed
DCM
81
Dupont Capital Management
Delaware
-$389K -13,268 Closed
MFS
82
Mirabella Financial Services
United Kingdom
-$343K -11,691 Closed
Jane Street
83
Jane Street
New York
-$321K -10,959 Closed
UBS Group
84
UBS Group
Switzerland
-$18K -613 Closed
MAM
85
Meeder Asset Management
Ohio
-$11K -403 Closed
FFA
86
Founders Financial Alliance
North Carolina
-$1K -60 Closed